Adult Study to Evaluate Placement of Tympanostomy Tubes In-office (ADEPT)
ADEPT
ADEPT
A Prospective, Multicenter Study to Evaluate Effectiveness and Safety of Lidocaine Iontophoresis and Tympanostomy Tube Placement Using the Tula Iontophoresis and Tube Delivery Systems for Adults in an Office Setting
Sponsor study identifier
interventional
30
1 country
8
Study Start
June 27, 2017
Actual (reported)Primary Completion
September 14, 2017
Actual (reported)Study Completion
September 14, 2017
Actual (reported)A prospective, multicenter study to evaluate effectiveness and safety of Tymbion iontophoresis and tympanostomy tube placement using the Tula iontophoresis and tube delivery systems for adults in an office setting. This study cohort is called Group B and includes tube placement. Protocol CPR007003 also included a first study group ('A', without tube placement) that was completed and described in a separate registration (NCT03119181).
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
September 14, 2017
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
June 20, 2017
Actual (reported)June 23, 2017
Actual (reported)June 27, 2017
Actual (reported)September 14, 2017
Actual (reported)September 14, 2017
Actual (reported)January 18, 2020
Actual (reported)Subject-reported Pain Score Following Tube Delivery System (TDS) Tube Placement Using the Visual Analogue Scale (VAS) by Subject Compared to a Performance Goal.
The VAS consists of a 100 millimeter (mm) line with a statement at each end representing the extreme limits of pain intensity where a score of 0 represents "No pain" and a score of 100 represents "The worst possible pain". Following TDS tube placement, the subject will report their post-tube placement ear discomfort for each ear undergoing tube placement using the VAS. For subjects treated bilaterally, the highest (worst) score reported will be used as the unit of analysis.
Day of procedure (Day 0)- Immediately after tube placement
Active Tymbion iontophoresis and tube insertion using the TDS
Subjects will receive active Tymbion iontophoresis and tube insertion using the Tube Delivery System in all ears indicated for tube placement.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Sacramento ENT
Roseville, California, 95661, United States
Camino ENT
San Jose, California, 95138, United States
Advanced ENT and Allergy
Louisville, Kentucky, 40207, United States
Charlotte Eye Ear Nose and Throat Associates
Charlotte, North Carolina, 28105, United States
Specialty Physician Associates
Bethlehem, Pennsylvania, 18017, United States
South Carolina ENT
Lugoff, South Carolina, 29078, United States
Carolina Ear, Nose and Throat
Orangeburg, South Carolina, 29118, United States
David Yen, MD
Specialty Physician Associates
30 participants (actual enrollment reported by the registry).
First Submitted
June 20, 2017
First Posted
June 23, 2017
Study Start
June 27, 2017
Actual (reported)Primary Completion
XprESS Eustachian Tube Dilation Study
Contact the study team to confirm eligibility.
Ear Medical Group
San Antonio, Texas, 78240, United States
September 14, 2017
Actual (reported)Study Completion
September 14, 2017
Actual (reported)Last Updated
January 18, 2020
Results First Posted
January 18, 2020
Record last verified: 2020-01
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: